Renaissance Technologies’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,444
| Closed | -$32K | – | 3945 |
|
|
2023
Q4 | $32K | Buy |
4,444
+2,763
| +164% | +$19.9K | ﹤0.01% | 3520 |
|
|
2023
Q3 | $26K | Buy |
1,681
+397
| +31% | +$6.14K | ﹤0.01% | 3500 |
|
|
2023
Q2 | $34K | Buy |
1,284
+749
| +140% | +$19.8K | ﹤0.01% | 3681 |
|
|
2023
Q1 | $32K | Buy |
535
+37
| +7% | +$2.21K | ﹤0.01% | 3749 |
|
|
2022
Q4 | $34K | Buy |
498
+119
| +31% | +$8.12K | ﹤0.01% | 3869 |
|
|
2022
Q3 | $51K | Buy |
379
+45
| +13% | +$6.06K | ﹤0.01% | 3751 |
|
|
2022
Q2 | $102K | Buy |
334
+170
| +104% | +$51.9K | ﹤0.01% | 3848 |
|
|
2022
Q1 | $60K | Buy |
164
+60
| +58% | +$22K | ﹤0.01% | 3882 |
|
|
2021
Q4 | $48K | Buy |
104
+53
| +104% | +$24.5K | ﹤0.01% | 3786 |
|
|
2021
Q3 | $40K | Buy |
+51
| New | +$40K | ﹤0.01% | 3387 |
|
|
2021
Q1 | – | Sell |
-327
| Closed | -$279K | – | 3578 |
|
|
2020
Q4 | $279K | Sell |
327
-173
| -35% | -$148K | ﹤0.01% | 3058 |
|
|
2020
Q3 | $448K | Buy |
500
+283
| +130% | +$254K | ﹤0.01% | 2850 |
|
|
2020
Q2 | $306K | Buy |
217
+156
| +256% | +$220K | ﹤0.01% | 3034 |
|
|
2020
Q1 | $45K | Sell |
61
-113
| -65% | -$83.4K | ﹤0.01% | 3333 |
|
|
2019
Q4 | $136K | Sell |
174
-110
| -39% | -$86K | ﹤0.01% | 3260 |
|
|
2019
Q3 | $212K | Sell |
284
-53
| -16% | -$39.6K | ﹤0.01% | 3127 |
|
|
2019
Q2 | $697K | Buy |
337
+313
| +1,304% | +$647K | ﹤0.01% | 2866 |
|
|
2019
Q1 | $36K | Buy |
24
+4
| +20% | +$6K | ﹤0.01% | 3374 |
|
|
2018
Q4 | $18K | Buy |
20
+6
| +43% | +$5.4K | ﹤0.01% | 3327 |
|
|
2018
Q3 | $34K | Buy |
+14
| New | +$34K | ﹤0.01% | 3300 |
|
|
2017
Q2 | – | Sell |
-9
| Closed | -$42K | – | 3311 |
|
|
2017
Q1 | $42K | Sell |
9
-12
| -57% | -$56K | ﹤0.01% | 3151 |
|
|
2016
Q4 | $83K | Sell |
21
-9
| -30% | -$35.6K | ﹤0.01% | 3123 |
|
|
2016
Q3 | $149K | Sell |
30
-2
| -6% | -$9.93K | ﹤0.01% | 3122 |
|
|
2016
Q2 | $99K | Buy |
32
+5
| +19% | +$15.5K | ﹤0.01% | 3162 |
|
|
2016
Q1 | $69K | Buy |
27
+11
| +69% | +$28.1K | ﹤0.01% | 3250 |
|
|
2015
Q4 | $40K | Buy |
16
+9
| +129% | +$22.5K | ﹤0.01% | 3195 |
|
|
2015
Q3 | $62K | Sell |
7
-1
| -13% | -$8.86K | ﹤0.01% | 3058 |
|
|
2015
Q2 | $155K | Sell |
8
-1
| -11% | -$19.4K | ﹤0.01% | 3030 |
|
|
2015
Q1 | $187K | Buy |
9
+3
| +50% | +$62.3K | ﹤0.01% | 2899 |
|
|
2014
Q4 | $120K | Buy |
6
+2
| +50% | +$40K | ﹤0.01% | 2776 |
|
|
2014
Q3 | $111K | Buy |
4
+3
| +300% | +$83.3K | ﹤0.01% | 2646 |
|
|
2014
Q2 | $31K | Buy |
+1
| New | +$31K | ﹤0.01% | 2729 |
|
|
2013
Q3 | – | Hold |
0
| – | -$21K | – | 2901 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 2735 |
|